Regeneron Pharmaceuticals Inc. buy Sanford C. Bernstein
Start price
12.03.24
/
50%
€887.00
Target price
12.03.25
€1,030.6
Performance (%)
-28.55%
End price
13.03.25
€633.80
Summary
This prediction ended on 13.03.25 with a price of €633.80. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.55%. Sanford_C__Bernstein has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €0.84 are taken into consideration when calculating the performance. Sanford_C__Bernstein has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.447% | -1.447% | -0.388% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,125.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten
Current prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€506.20
27.08.25
27.08.25
€671.27
27.08.26
27.08.26
32.20%
23.02.26
23.02.26
Stopped prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€705.20
07.01.25
07.01.25
€1,031.8
07.01.26
07.01.26
-2.21%
08.01.26
08.01.26